Risk Stratification Scores for Hospitalization Duration and Disease Progression in Moderate and Severe Patients With COVID-19

Jiaqi Huang; Yu Xu; Bin Wang; Ying Xiang; Na Wu; Wenjing Zhang; Tingting Xia; Zhiquan Yuan; Chengying Li; Xiaoyue Jia; Yifan Shan; Menglei Chen; Qi Li; Li Bai; Yafei Li

Disclosures

BMC Pulm Med. 2021;21(120) 

In This Article

Conclusions

In summary, we found that moderate COVID-19 patients with more clinical symptoms, elevated platelet count, CRP and LDH, lower albumin at admission and higher body temperature during hospitalization had a high probability of longer hospital stay; severely ill patients having a history of respiratory disease, higher NLR, creatinine, LDH, and PT, lower platelet count at admission, and higher body temperature during hospitalization had a higher risk for disease progression. Using these clinical features and routine blood test indexes, we constructed two easy-to-use risk stratification score systems, named as STPCAL and TRPNCLP, to predict hospitalization duration and disease progression, respectively. In the current COVID-19 pandemic and the absence of specific remedies, early risk prediction and stratification will contribute to precise management of patients and effective use of limited health resources.

Reporting Guideline Statement

We present this article in accordance with the STROBE reporting checklist.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....